Development of HIV vectors for anti-HIV gene therapy.
Current gene therapy protocols for HIV infection use transfection or murine retrovirus mediated transfer of antiviral genes into CD4+ T cells or CD34+ progenitor cells ex vivo, followed by infusion of the gene altered cells into autologous or syngeneic/allogeneic recipients. While these studies are...
Na minha lista:
| 發表在: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
National Academy of Sciences
1996
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC38068/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8876146/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.21.11395 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|